- Home
- SEV vs CLNN Comparison
SEV vs CLNN Comparison
Compare SEV & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEV | CLNN |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.2M | 120.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SEV | CLNN |
|---|---|---|
| Price | $5.52 | $6.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 138.5K | ★ 318.3K |
| Earning Date | 11-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $87.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.55 | $2.28 |
| 52 Week High | $22.43 | $13.50 |
Technical Indicators
Market Signals| Indicator | SEV | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.94 |
| Support Level | N/A | $5.42 |
| Resistance Level | N/A | $7.03 |
| Average True Range (ATR) | 0.00 | 0.98 |
| MACD | 0.00 | -0.21 |
| Stochastic Oscillator | 0.00 | 16.61 |
Price Performance
Historical ComparisonAbout SEV Aptera Motors Corp.
Aptera Motors Corp develops and produces energy-efficient solar-powered, battery-electric vehicles designed to maximize solar energy utilization. The company focuses on lightweight composite structures and solar technology to minimize environmental impact and reduce reliance on charging infrastructure.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.